Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus

Hepatology

Volumn 36, Issue 5, 2002, Pages 1206-1213

  Hassan, Manal M ^a   Hwang, Lu Yu ^b   Hatten, Chiq J ^a   Swaim, Mark ^a   Li, Donghui ^a   Abbruzzese, James L ^a   Beasley, Palmer ^b   Patt, Yehuda Z ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; VIRUS HEPATITIS;

EID: 0036829556     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.36780     Document Type: Article

References (38)

1. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr. International trends and patterns of primary liver cancer. Int J Cancer 2000;94:290-296.
2. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
3. International Agency for Research on Cancer (IARC). Hepatitis Viruses. Vol 59. Lyon, France: IARC Monogr Eval Carcinog Risks Hum, 1994.
4. Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Gamil F, Madkour S, et al. Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity. Hepatology 2001;33:248-253.
5. Hassan MM, Zaghloul AS, El Serag HB, Soliman O, Patt YZ, Chappell CL, Beasley RP, et al. The role of hepatitis C in hepatocellular carcinoma: A case control study among Egyptian patients. J Clin Gastroenterol 2001;33:123-126.
6. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990;82:1038-1041.
7. International Agency for Research on Cancer (IARC). Alcohol Drinking. Vol 44. Lyon, France: IARC Monogr Eval Carcinog Risks Hum, 1988.
8. Brown JJ, Naylor MJ, Yagan N. Imaging of hepatic cirrhosis. Radiology 1997;202:1-16.
9. Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol 1976;103:506-511.
10. Bosch FX, Munoz N. Hepatocellular Carcinoma in the World: epidemiologic questions. In: Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston, Texas: Gulf Publishing Company, 1991;35-54.
11. Kew MC. Hepatitis B and C viruses and hepatocellular carcinoma. Clin Lab Med 1996;16:395-406.
12. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med 1998;4:1065-1067.
13. Ray RB, Meyer K, Ray R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 1996;226:176-182.
14. Austin H, Delzell E, Grufferman S, Levine R, Morrison AS, Stolley PD, Cole P. A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res 1986;46:962-966.
15. Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, Gelatti U, Albertini A, et al. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study. Int J Cancer 1999;81:695-699.
16. Peguignot G, Chabert C, Eydoux H, Corcowl MA. Increased risk of liver cirrhosis with intake of alcohol. Rev Alcoholism 1974;20:191-202.
17. Caetano R, Clark CL. Trends in alcohol consumption patterns among whites, blacks and Hispanics: 1984 and 1995. J Stud Alcohol 1998;59:659-668.
18. Batey RG, Burns T, Benson RJ, Byth K. Alcohol consumption and the risk of cirrhosis. Med J Aust 1992;156:413-416.
19. Lieber CS, Seitz HK, Garro AJ, Worner TM. Alcohol-related diseases and carcinogenesis. Cancer Res 1979;39:2863-2886.
20. Lieber CS. Mechanism of ethanol induced hepatic injury. Pharmacol Ther 1990;46:1-41.
21. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-1826.
22. La Vecchia C, Negri E, Decarli A, Franceschi S. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997;73:204-207.
23. Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami HO. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000;92:1096-1099.
24. Resnick HE, Valsania P, Halter JB, Lin X. Differential effects of BMI on diabetes risk among black and white Americans. Diabetes Care 1998;21:1828-1835.
25. Moore MA, Park CB, Tsuda H. Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts. Eur J Cancer Prev 1998;7:89-107.
26. Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, Norris HT, et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990;85:1349-1355.
27. Breslow NE, Day NE. The analysis of case-control studies. In: International Agency for Research on Cancer. Statistical Methods in Cancer Research. Vol 1. Lyon, France: IARC, 1980:42-81.
28. Rothman KJ. Interactions between causes. In: Modern Epidemiology. Boston: Little Brown and Company, 1986:311-326.
29. Kleinbaum DG, Kupper LL, Morgenstern H. Interactions. Effect modification and synergism. In: Epidemiologic Research. New York: Van Nostrand Reinhold, 1982:407-417.
30. Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Barton S, Lemoch H, Sudhop T, et al. Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection. Eur J Clin Nutt 1997;51:266-272.
31. Zhang W, Cox AG, Taylor EW. Hepatitis C virus encodes a selenium-dependent glutathione peroxidase gene. Implications for oxidative stress as a risk factor in progression to hepatocellular carcinoma. Med Klin 1999;94(Suppl 3):2-6.
32. Brechot C, Nalpas B, Feitelson MA. Interactions between alcohol and hepatitis viruses in the liver. Clin Lab Med 1996;16:273-287.
33. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCOMCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001;17:189-212.
34. Kar M, Chakraborti AS. Release of iron from haemoglobin - A possible source of free radicals in diabetes mellitus. Indian J Exp Biol 1999;37:190-192.
35. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 1999;22:1978-1983.
36. Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1988;5:113-124.
37. Gillery P, Monboisse JC, Maquart FX, Borel JP. Does oxygen free radical increased formation explain long term complications of diabetes mellitus? Med Hypotheses 1989;29:47-50.
38. Schlesselman JJ, Stolley PD. Sources of bias. In: Schlesselman JJ, ed. Case-Control Studies Design, Conduct, Analysis. New York: Oxford, 1982:124-143.